Medicare Enrolled
Dr. Koteshwar Telukuntla, MD
Hematology · Bradenton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Telukuntla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Telukuntla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Telukuntla
Dr. Koteshwar Telukuntla is a hematology specialist in Bradenton, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Telukuntla performed 166,492 Medicare services across 4,969 unique beneficiaries.
Between the years covered by Open Payments, Dr. Telukuntla received a total of $12,957 from 88 pharmaceutical and/or device companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Telukuntla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in FL
$12,957 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 72534 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗166,492
Medicare services
Top 30% in FL for hematology
4,969
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,325 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 39,600 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 22,500 | $18 | $51 |
| Iron infusion (Feraheme) | 20,910 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 18,420 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 15,400 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 7,691 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 6,110 | $1 | $5 |
| Golimumab infusion (Simponi Aria) | 5,800 | $10 | $56 |
| Immune globulin infusion (Gammagard) | 5,078 | $36 | $108 |
| Paclitaxel chemotherapy injection | 4,205 | $0 | $2 |
| Injection, rituximab, 10 mg | 4,080 | $64 | $232 |
| Blood draw (venipuncture) | 2,903 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,613 | $8 | $29 |
| Dexamethasone injection (steroid) | 1,441 | $0 | $3 |
| Office visit, established patient (20-29 min) | 1,291 | $65 | $239 |
| Infliximab infusion (Remicade) | 1,270 | $26 | $124 |
| Anti-nausea injection (Aloxi/palonosetron) | 900 | $1 | $28 |
| Drug injection, under skin or into muscle | 881 | $10 | $69 |
| Injection, leucovorin calcium, per 50 mg | 544 | $3 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 453 | $96 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 452 | $0 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 418 | $47 | $189 |
| Injection of additional new drug or substance into vein | 356 | $11 | $61 |
| Injection, fluorouracil, 500 mg | 342 | $2 | $7 |
| Administration of chemotherapy into vein, each additional hour | 242 | $21 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 222 | $15 | $56 |
| Hospital follow-up visit, low complexity | 206 | $39 | $109 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 190 | $22 | $84 |
| Office visit, established patient (30-39 min) | 187 | $97 | $339 |
| Injection, zoledronic acid, 1 mg | 183 | $7 | $69 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 169 | $17 | $59 |
| Injection, diphenhydramine hcl, up to 50 mg | 162 | $1 | $3 |
| Injection, carboplatin, 50 mg | 131 | $2 | $41 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 120 | $65 | $281 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 119 | $1 | $6 |
| New patient office visit (30-44 min) | 98 | $82 | $298 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 81 | $3 | $11 |
| Administration of additional new drug or substance into vein, 1 hour or less | 65 | $49 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | $25 | $89 |
| Injection of drug or substance into vein | 55 | $27 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 51 | $51 | $206 |
| Administration of additional new drug or substance into vein using push technique | 49 | $42 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 46 | $133 | $562 |
| Office visit, established patient (10-19 min) | 43 | $38 | $147 |
| New patient office visit (45-59 min) | 42 | $120 | $453 |
| Infusion into a vein for hydration, each additional hour | 37 | $10 | $42 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 36 | $126 | $637 |
| Drawing of blood for a medical problem | 35 | $70 | $277 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 34 | $15 | $56 |
| Red blood count automated, with additional calculations | 32 | $5 | $20 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 32 | $1 | $7 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 31 | $4 | $15 |
| Automated urinalysis | 28 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 26 | $25 | $156 |
| Infusion, normal saline solution , 1000 cc | 24 | $2 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.5% high complexity
74.8% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,957
Total received (2018-2024)
Avg $1,851/year across 7 years
Top 37% in FL for hematology
88
Companies
728
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,586 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$371 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,028
2023
$2,169
2022
$937
2021
$1,610
2020
$656
2019
$2,812
2018
$1,745
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,299
Novartis Pharmaceuticals Corporation
$1,134
PFIZER INC.
$885
Genentech USA, Inc.
$670
Merck Sharp & Dohme Corporation
$660
Merck Sharp & Dohme LLC
$564
Janssen Biotech, Inc.
$548
Celgene Corporation
$499
Amgen Inc.
$458
Lilly USA, LLC
$454
Daiichi Sankyo Inc.
$443
Gilead Sciences, Inc.
$397
Astellas Pharma US Inc
$321
AstraZeneca Pharmaceuticals LP
$292
Incyte Corporation
$291
GlaxoSmithKline, LLC.
$253
BeiGene USA, Inc.
$237
Seagen Inc.
$211
GENZYME CORPORATION
$136
Taiho Oncology, Inc.
$130
Pharmacyclics LLC, An AbbVie Company
$129
Takeda Pharmaceuticals U.S.A., Inc.
$127
ARRAY BIOPHARMA INC
$126
ABBVIE INC.
$115
TerSera Therapeutics LLC
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
SEAGEN INC.
$100
Karyopharm Therapeutics Inc.
$97
Kite Pharma, Inc.
$94
Rigel Pharmaceuticals, Inc.
$84
JAZZ PHARMACEUTICALS INC.
$82
SANOFI-AVENTIS U.S. LLC
$82
Exelixis Inc.
$81
Bayer HealthCare Pharmaceuticals Inc.
$80
Eisai Inc.
$78
Janssen Products, LP
$77
ARALEZ PHARMACEUTICALS US INC.
$72
Regeneron Healthcare Solutions, Inc.
$65
Puma Biotechnology, Inc.
$62
AbbVie Inc.
$56
SOBI, INC
$53
Dendreon Pharmaceuticals LLC
$52
Janssen Pharmaceuticals, Inc
$46
Stemline Therapeutics Inc.
$45
Myovant Sciences Inc.
$42
EISAI INC.
$42
AbbVie, Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$41
AMAG Pharmaceuticals, Inc.
$39
SERVIER PHARMACEUTICALS LLC
$38
Alnylam Pharmaceuticals Inc.
$37
SpringWorks Therapeutics, Inc.
$36
Clovis Oncology, Inc.
$36
TAIHO ONCOLOGY, INC.
$36
PharmaEssentia USA Corporation
$34
EMD Serono, Inc.
$33
MorphoSys, US Inc.
$31
Dova Pharmaceuticals
$30
INSYS Therapeutics Inc
$30
Helsinn Therapeutics (U.S.), Inc.
$30
Spectrum Pharmaceuticals Inc.
$29
Sysmex Inostics Inc
$27
Sun Pharmaceutical Industries Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Tempus AI, Inc
$23
Legend Biotech USA Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Sobi, Inc
$19
Mirati Therapeutics, Inc.
$18
TESARO, Inc.
$18
Blueprint Medicines Corporation
$18
TG Therapeutics, Inc.
$18
Array BioPharma Inc.
$18
R-Pharm US LLC
$17
Seattle Genetics, Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Aveo Pharmaceuticals, Inc.
$17
Epizyme, Inc.
$17
EUSA Pharma (US) LLC
$17
Kyowa Kirin, Inc.
$17
Epizyme, Inc.,
$15
Sumitomo Pharma America, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$14
Horizon Pharma plc
$14
Alexion Pharmaceuticals, Inc.
$13
PORTOLA PHARMACEUTICALS, INC.
$13
Heron Therapeutics, Inc.
$7
Veracyte, Inc.
$0
Top 3 companies account for 25.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIMPONI ARIA · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZONTIVITY · ZYTIGA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
19
Per 100K population
4.6
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Telukuntla is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Telukuntla experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Telukuntla performed 39,600 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Telukuntla receive payments from pharmaceutical companies?
Yes. Dr. Telukuntla received a total of $12,957 from 88 companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Telukuntla's costs compare to other hematologists in Bradenton?
Dr. Telukuntla's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Telukuntla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Bradenton
Browse hematologists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology